Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × ALT-803 × 30 days × Clear all

Phase

Status

Recruiting 4 Active not recruiting 2 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Prednisone 2 tislelizumab 1 tazemetostat 1 tafasitamab 1 semaglutide 1 ribociclib 1 pembrolizumab 1 niraparib 1 monalizumab 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 auricularum 1 atezolizumab 1 Vincristine 1 Tiragolumab 1 Surveys and Questionnaires 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Quality Assurance, Health Care 1 Prednisolone 1 Physical Therapy Modalities 1 Patient Education as Topic 1 Nivolumab 1 Neoadjuvant Therapy 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07049432 2026-04-01

CARMEN-803

University of Utah

Phase 1 Withdrawn

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡